M1T (p.Met1Thr) variant of GLA (Alpha-galactosidase A)
M1T (p.Met1Thr) in GLA (Alpha-galactosidase A) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of not provided; Fabry disease. The available variant effect predictions contribute to a CATVariant prioritization score of 0.90 / 1. The record also includes published literature and structural context.
M1T (p.Met1Thr) variant details
- p.Met1Thr
- rs1555987232
- ClinGen CA413937947
- ClinVar RCV000586866
- ClinVar RCV000731977
- Pathogenic
- not provided; Fabry disease
- Missense
- Variant Prioritization Score for Impact Estimate 0.902
- MetaLR 0.99
- MetaSVM 1.59
- PolyPhen-2 0.15
- SIFT 0.00
- MutPred 0.99
- ClinVar: Pathogenic (not provided; Fabry disease)
- EBI: Pathogenic
- UniProt: Pathogenic
- Structural context available
- Cited in: Fabry disease in genetic counseling practice: recommendations of the National Society of Genetic Counselors. (PMID 12735292)
- Cited in: Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. (PMID 16980809)